Immunoassays Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Immunoassays Market is segmented by Type (Radioimmunoassay, Enzyme Immunoassays, Fluoroimmnoassay, Chemiluminescenceimmunoassay, Others), Application, End User and Geography

Market Snapshot

Immunoassays Market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.8 %
 Immunoassays Market Research

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Factors that are responsible for the growth of immunoassays market include cost-effectiveness, growth in the biotechnology and pharmaceutical sectors, and high sensitivity and specificity of immunoassays.

Compared to conventional tests, immunoassays have been proven to provide highly accurate results even with very small samples. These immunoassays are considered to have a detection limit of 1pg/ml, which can be attributed to the fact that immunoassays are based entirely on immunologic reactions. Immunologic reactions are highly specific, as they can take place only in the presence of proper immunologic agents. For instance, an antibody against a viral protein cannot bind with an antigen that is derived from bacteria. This high specificity indicates high accuracy in results, which enable high sensitivity in the detection of diseases. This high sensitivity not only helps in easy detection but also eliminates the need for secondary verifications, which ultimately saves a lot of costs. Thus, the high sensitivity, specificity, and cost-saving nature of immunoassays are driving the growth of the immunoassays market. However, factors, such as complex assay procedures and limitations associated with immunoassays, may hinder the market growth.

Scope of the Report

An immunoassay is a test that relies on biochemistry to measure the presence and concentration of an analyte. The analyte can be large proteins, antibodies that a person has produced as a result of an infection or small molecules. Immunoassays are highly sensitive and specific. Their high specificity results from the use of antibodies and purified antigens as reagents.

By Type
Radioimmunoassay (RIA)
Enzyme Immunoassays (EIA)
Fluoroimmnoassay (FIA)
Chemiluminescenceimmunoassay(CLIA)
Others
By Application
Disease Diagnosis
Therapeutic Drug Monitoring
Drug Discovery
Clinical Chemistry
Hematology
Others
By End User
Hospitals
Pharma & Biotech Companies
Clinical Laboratories
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Enzyme Immunoassays (EIA) Segment is Expected to Hold Significant Market Share in Global Immunoassay Market

  • In enzyme immunoassay (EIA), the immunologic agent is attached to an enzyme. Upon the immunologic reaction, the enzyme is released from the immunologic agent. It then reacts with the substrate, resulting in a color change. The assay results are directly proportional to the intensity of color change. EIAs are also known as enzyme-linked immunosorbent assays (ELISAs).
  • EIAs are easy to perform, require little specialized equipment, and both experienced lab technicians and the research lab novice can learn EIA skills quickly. However, a better understanding of the elements and design of EIAs is useful.
  • Due to the simple working principle, enzyme immunoassays are the most cost-effective among all the immunoassays. Consequently, they have the largest share in the global immunoassay market.
Immunoassays Market Share

North America Dominates the Market and is Expected to do Same during the Forecast Period

Currently, North America dominates the market for immunoassays and is expected to continue its stronghold for a few more years. In the North American region, the United States holds the largest market share. This can be majorly attributed to the increasing incidence rates of chronic disorders, infectious diseases, increasing number of geriatric population, as well as due to the well-developed healthcare infrastructure and increasing penetration of medical devices in the region. Moreover, high expenditure on R&D by government organizations and pharmaceutical companies, for disorders and diseases, such as chronic ailments and diabetes, are some of the primary factors driving the regional market.

Immunoassays Market Size

Competitive Landscape

The immunoassays market is moderately competitive and consists of several major players. In terms of the market share, few of the major players currently dominate the market. With rising need for healthcare development and the advances in immunoassays, few other smaller players are expected to enter the market. Some of the major players of the market are Abbott Laboratories Inc., Becton Dickinson and Company, Danaher Corporation, Hologic Inc., and Qiagen NV, among others.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 High Sensitivity and Specificity of Immunoassays

      2. 4.2.2 Technological Advancements in Immunoassay Instruments

      3. 4.2.3 Increasing Prevalence of Chronic and Infectious Diseases

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory Scenario for Approval of Immunoassays

      2. 4.3.2 Complexity of Procedures

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 Radioimmunoassay (RIA)

      2. 5.1.2 Enzyme Immunoassays (EIA)

      3. 5.1.3 Fluoroimmnoassay (FIA)

      4. 5.1.4 Chemiluminescenceimmunoassay(CLIA)

      5. 5.1.5 Others

    2. 5.2 By Application

      1. 5.2.1 Disease Diagnosis

      2. 5.2.2 Therapeutic Drug Monitoring

      3. 5.2.3 Drug Discovery

      4. 5.2.4 Clinical Chemistry

      5. 5.2.5 Hematology

      6. 5.2.6 Others

    3. 5.3 By End User

      1. 5.3.1 Hospitals

      2. 5.3.2 Pharma & Biotech Companies

      3. 5.3.3 Clinical Laboratories

      4. 5.3.4 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East & Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East & Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Becton Dickinson and Company

      3. 6.1.3 Danaher Corporation

      4. 6.1.4 Devon Medical Products

      5. 6.1.5 EDP Biotech Corporation

      6. 6.1.6 Hologic Inc.

      7. 6.1.7 Luminex Corporation

      8. 6.1.8 Meridian Life Science Inc.

      9. 6.1.9 Qiagen NV

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Immunoassays Market market is studied from 2018 - 2026.

The Immunoassays Market is growing at a CAGR of 7.8% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Abbott Laboratories Inc., Becton Dickinson and Company, Danaher Corporation, Hologic Inc., Qiagen NV are the major companies operating in Immunoassays Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!